(Q40338040)
Statements
Treatment of primary central nervous system lymphoma with induction of complement-dependent cytotoxicity by intraventricular administration of autologous-serum-supplemented rituximab (English)
Tomoe Hayashi
Daisuke Kita
Ryosei Nishimura
Hidesaku Asakura
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference